Literature DB >> 25104088

MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells.

Guoqiang Zhang1, Zengyan Liu, Guanghe Cui, Xiaohong Wang, Zhenlin Yang.   

Abstract

MicroRNAs (miRNAs) are emerging as critical regulators in carcinogenesis and tumor progression. Recently, miR-486-5p has been proved to play an important role in several cancers, but its functions in the context of breast cancer (BC) remain unknown. In this study, we found that miR-486-5p expression is significantly downregulated in BC tissues and cell lines. Overexpression of miR-486-5p dramatically suppressed BC cell proliferation in vitro and in vivo, induced G0/G1 arrest, and promoted apoptosis. We subsequently identified the oncogene PIM-1 as a direct target of miR-486-5p in BC. Overexpression of PIM-1 attenuated the function of miR-486-5p in BC cells. Together, we conclude that miR-486-5p exerts its antiproliferative function by directly downregulating PIM-1 expression. This novel miR-486-5p/PIM-1 axis provides insight into the pathogenesis of BC and might be therapeutic targets for prevention or treatment of BC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25104088     DOI: 10.1007/s13277-014-2412-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

1.  The proto-oncogene Pim-1 is a target of miR-33a.

Authors:  M Thomas; K Lange-Grünweller; U Weirauch; D Gutsch; A Aigner; A Grünweller; R K Hartmann
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

2.  Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486.

Authors:  Eric M Small; Jason R O'Rourke; Viviana Moresi; Lillian B Sutherland; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

Review 3.  MicroRNA regulation by RNA-binding proteins and its implications for cancer.

Authors:  Marieke van Kouwenhove; Martijn Kedde; Reuven Agami
Journal:  Nat Rev Cancer       Date:  2011-08-05       Impact factor: 60.716

4.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

5.  Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.

Authors:  Marco Ragusa; Alessandra Majorana; Luisa Statello; Marco Maugeri; Loredana Salito; Davide Barbagallo; Maria Rosa Guglielmino; Laura R Duro; Rosario Angelica; Rosario Caltabiano; Antonio Biondi; Maria Di Vita; Giuseppe Privitera; Marina Scalia; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Francesco Basile; Cinzia Di Pietro; Michele Purrello
Journal:  Mol Cancer Ther       Date:  2010-09-29       Impact factor: 6.261

6.  Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.

Authors:  Yutaka Midorikawa; Shogo Yamamoto; Shingo Tsuji; Naoko Kamimura; Shumpei Ishikawa; Hisaki Igarashi; Masatoshi Makuuchi; Norihiro Kokudo; Haruhiko Sugimura; Hiroyuki Aburatani
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.

Authors:  Laisheng Li; Jinmei Luo; Bo Wang; Dong Wang; Xinhua Xie; Linjing Yuan; Jiaoli Guo; Shaoyan Xi; Jie Gao; Xiaoti Lin; Yanan Kong; Xiangdong Xu; Hailing Tang; Xiaoming Xie; Min Liu
Journal:  Mol Cancer       Date:  2013-12-13       Impact factor: 27.401

9.  A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells.

Authors:  Meejeon Roh; Omar E Franco; Simon W Hayward; Riet van der Meer; Sarki A Abdulkadir
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

10.  Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation.

Authors:  Ola A Elgamal; Jong-Kook Park; Yuriy Gusev; Ana Clara P Azevedo-Pouly; Jinmai Jiang; Avtar Roopra; Thomas D Schmittgen
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  34 in total

1.  Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.

Authors:  Yunfeng Yi; Xiujuan Lu; Jianming Chen; Changjie Jiao; Jing Zhong; Zhiming Song; Xiaoping Yu; Baoli Lin
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

2.  Differential expression of circulating microRNAs according to severity of colorectal neoplasia.

Authors:  Gloria Y F Ho; Hwa Jin Jung; Robert E Schoen; Tao Wang; Juan Lin; Zev Williams; Joel L Weissfeld; Jung Yoon Park; Olivier Loudig; Yousin Suh
Journal:  Transl Res       Date:  2015-02-23       Impact factor: 7.012

3.  Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Authors:  Zhongguo Zhou; Rongxin Zhang; Ruojing Wang; Yaojun Zhang; Li Xu; Jinbin Chen; Jie Zhang; Zhongxi Huang; Minshan Chen; Zhizhong Pan
Journal:  Tumour Biol       Date:  2016-01-14

4.  ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.

Authors:  Mathewos Tessema; Christin M Yingling; Maria A Picchi; Guodong Wu; Tyrone Ryba; Yong Lin; Aaron O Bungum; Eric S Edell; Avrum Spira; Steven A Belinsky
Journal:  Cancer Lett       Date:  2017-09-29       Impact factor: 8.679

5.  MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.

Authors:  Xiao-Yu Liu; Zhi-Jian Liu; Hong He; Chen Zhang; Yun-Long Wang
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

6.  Expression profiles of circular RNAs in colon biopsies from Crohn's disease patients by microarray analysis.

Authors:  Yu-An Hu; Yan Zhu; Guorui Liu; Xinyue Yao; Xiaoling Yan; Yang Yang; Weiping Wang; Xiaoping Zou; Xiaojun Li
Journal:  J Clin Lab Anal       Date:  2021-05-06       Impact factor: 2.352

7.  MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.

Authors:  Su-Chen Li; Azita Monazzam; Masoud Razmara; Xia Chu; Peter Stålberg; Britt Skogseid
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

8.  Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.

Authors:  Hui Chen; Chuanli Ren; Chongxu Han; Daxin Wang; Yong Chen; Deyuan Fu
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy.

Authors:  Liming Wang; Mei Liu; Hongxia Zhu; Weiqi Rong; Fan Wu; Songlin An; Faqiang Liu; Li Feng; Jianxiong Wu; Ningzhi Xu
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

10.  miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma.

Authors:  Chengxia Liu; Ming Li; Yingbin Hu; Ning Shi; Haisheng Yu; Haiyan Liu; Haifeng Lian
Journal:  Onco Targets Ther       Date:  2016-05-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.